|
Sep 4
|
XOMA Royalty to Present at Upcoming Investor Conferences in September
|
|
Jun 21
|
Xoma (XOMA) Soars 15.6%: Is Further Upside Left in the Stock?
|
|
Jun 12
|
XOMA Receives $8.1 Million Milestone Related to Day One Biopharmaceuticals’ Sale of its Priority Review Voucher
|
|
May 14
|
XOMA to Present at H.C. Wainwright 2nd Annual Bioconnect Investor Conference at NASDAQ
|
|
May 10
|
XOMA Corp (XOMA) Q1 2024 Earnings: Misses Revenue Estimates, Reports Lower Net Loss
|
|
May 9
|
XOMA Reports First Quarter 2024 Financial Results and Highlights Recent Activities
|
|
May 7
|
Certara, Inc. (CERT) Q1 Earnings Meet Estimates
|
|
May 7
|
Xoma (XOMA) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
|
|
Apr 30
|
XOMA Adds Economic Interests in Three First-in-Category Assets to its Royalty and Milestone Portfolio Including XACIATO™ (clindamycin phosphate) Vaginal Gel 2%
|
|
Apr 25
|
XOMA Earns $9 Million Milestone as FDA Grants Accelerated Approval to Day One’s OJEMDATM (tovorafenib) for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG)
|
|
Apr 24
|
Actym Therapeutics Appoints Thomas Smart as CEO
|
|
Apr 20
|
XOMA (NASDAQ:XOMA) shareholders have earned a 16% CAGR over the last five years
|
|
Apr 3
|
XOMA Corporation Announces Closing of Tender Offer
|
|
Mar 19
|
XOMA Announces Calculation of Additional Price Per Share and Extension of Expiration Date for Tender Offer for Kinnate Biopharma Inc.
|
|
Mar 8
|
XOMA Corp (XOMA) Reports Mixed Financial Results for Q4 and Full Year 2023
|
|
Mar 8
|
XOMA Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent and Upcoming Events Expected to Drive Shareholder Value
|
|
Jan 11
|
FDA Acceptance of Zevra’s Arimoclomol NDA Filing for Niemann-Pick Disease Type C (NPC) Results in XOMA Making a $1 Million Milestone Payment to LadRx
|
|
Jan 8
|
XOMA Names Owen Hughes as Chief Executive Officer and Appoints Jack L. Wyszomierski as Chairman of the Board of Directors
|
|
Jan 2
|
XOMA Announces Stock Repurchase Program of up to $50 Million
|
|
Dec 20
|
XOMA Declares Quarterly Preferred Stock Dividends
|